Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Director | Common Stock | 121K | $3.52M | $29.06 | Feb 23, 2024 | Direct |
SUPERNUS PHARMACEUTICALS, INC. | Director | Restricted Stock Unit | 0 | $0 | $29.06 | Feb 23, 2024 | Direct |
SUPERNUS PHARMACEUTICALS, INC. | Director | Director Stock Option (Right to Buy) | 8.25K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 23, 2024 | 2 | $0 | 4 | Feb 27, 2024 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Nov 16, 2023 | 3 | -$1.12K | 4 | Nov 20, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 23, 2023 | 2 | $0 | 4 | Feb 27, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Dec 31, 2022 | 1 | $0 | 5 | Feb 8, 2023 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Dec 28, 2022 | 2 | $68.9K | 4 | Dec 30, 2022 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2022 | 2 | $0 | 4 | Feb 24, 2022 | Director |
SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 19, 2022 | 2 | $0 | 4 | Feb 23, 2022 | Director |